Clinical Trials Lab

The Clinical Trials Lab at Marcus Autism Center develops and tests pharmacological and behavioral interventions for children with autism spectrum disorder (ASD).

Current studies

Recent accomplishments

The randomized phase of the Direct Instruction Language for Leaning study is now completed. 83 children ages 4 to 7 participated. Half the children in the Direct Instruction group findings showed improvement in the use of language compared to 25% in the children in the community treatment control condition. On a commonly used language test, both groups improved. The Direct Instruction group did slightly better than the control group.

In late 2019, Lawrence Scahill, PhD, MSN, Director of Clinical Trials at Marcus Autism Center and colleagues from Ohio State University and Children's Hospital of Philadelphia published a report on a new parent-rated scale for anxiety in children with ASD (PRAS-ASD). This scale is now being used in several clinics in the U.S. and Europe.

Contact information

Rebecca Kilbourne

Faculty members and collaborators

Lawrence Scahill, MSN, PhD